Dissecting the immune cell mayhem that drives lupus pathogenesis.
Level V
Where this comes from
- Record sourced from PubMed, PMID 21389262.
- Also identified by DOI 10.1126/scitranslmed.3002138 and PMC identifier 3694130.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The autoimmune disease systemic lupus erythematosus (SLE) results from an inability of the immune system to discriminate between certain self-antigens and foreign ones. The most common treatment of SLE involves the use of immunosuppressive drugs to reduce inflammation, but these therapies have serious side effects. Three recent papers in Science Translational Medicine redirect focus on neutrophils, platelets, and interferon-α in the pathogenesis of SLE and reinforce the notion that researchers should seek to discover and devise combination therapies that target these processes.
Medical subject headings
- Lupus Erythematosus, Systemic